The University of Manchester is a public research university in Manchester, England. The main campus is south of Manchester City Centre on Oxford Road.

During the past decade, University of Manchester conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 8 clinical trials were completed, i.e. on average, 14.5% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 7 clinical trials were completed. i.e. 23.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Manchester" #1 sponsor was "University of Manchester" with 32 trials, followed by "Johnson & Johnson Vision Care, Inc." with 8 trials sponsored, "Coopervision, Inc." with 2 trials sponsored, "Alere San Diego" with 1 trials sponsored and "Augusta University" with 1 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Manchester" #1 collaborator was "University of Manchester" with 7 trials as a collaborator, "Manchester University NHS Foundation Trust" with 3 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 3 trials as a collaborator, "University of Leeds" with 3 trials as a collaborator and "Cargill" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "University of Manchester" are "Visual Acuity" (8 trials), "Depression" (4 trials), "Anxiety Disorder" (3 trials), "Obesity" (3 trials) and "Schizophrenia" (3 trials). Many other conditions were trialed in "University of Manchester" in a lesser frequency.

Most popular intervention types in "University of Manchester" are "Other" (18 trials), "Behavioral" (14 trials), "Device" (13 trials), "Drug" (9 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Volitional help sheet" (3 trials), "Glucose" (2 trials), "Maltodextrin" (2 trials) and "Transcranial direct current stimulation" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Manchester" are 65 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 13 active trials in "University of Manchester". 3 are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 43 completed trials in University of Manchester, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Manchester, 5 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 37 trials that are defined as “Not Applicable".

University of Manchester has several departments that took part in Clinical trials: "Christie Hospital; Breast Cancer Research Office" - 16 trials, "Department of Medical Oncology" - 3 trials